To investigate this, we tested our series for enrichment with respect to a cancer-associated fibroblast (CAF) signature previously described [25], inclusive of genes COL1A1, COL1A2, COL3A1, and PDGFRB, among others. The gene discussed is COL1A2; the disease is cancer.